116 related articles for article (PubMed ID: 11879702)
1. Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification.
Linnen JM; Gilker JM; Menez A; Vaughn A; Broulik A; Dockter J; Gillotte-Taylor K; Greenbaum K; Kolk DP; Mimms LT; Giachetti C
J Virol Methods; 2002 Apr; 102(1-2):139-55. PubMed ID: 11879702
[TBL] [Abstract][Full Text] [Related]
2. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.
Giachetti C; Linnen JM; Kolk DP; Dockter J; Gillotte-Taylor K; Park M; Ho-Sing-Loy M; McCormick MK; Mimms LT; McDonough SH
J Clin Microbiol; 2002 Jul; 40(7):2408-19. PubMed ID: 12089255
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of HCV RNA and HIV RNA blood screening assays.
Lelie PN; van Drimmelen HA; Cuypers HT; Best SJ; Stramer SL; Hyland C; Allain JP; Moncharmont P; Defer C; Nübling M; Glauser A; da Silva Cardoso M; Viret JF; Lankinen MH; Grillner L; Wirthmüller U; Coste J; Schottstedt V; Masecar B; Dax EM
Transfusion; 2002 May; 42(5):527-36. PubMed ID: 12084160
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
[TBL] [Abstract][Full Text] [Related]
6. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C
J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
Grabarczyk P; van Drimmelen H; Kopacz A; Gdowska J; Liszewski G; Piotrowski D; Górska J; Kuśmierczyk J; Candotti D; Lętowska M; Lelie N; Brojer E
Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
[TBL] [Abstract][Full Text] [Related]
9. Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.
Vargo J; Smith K; Knott C; Wang S; Fang C; McDonough S; Giachetti C; Caglioti S; Gammon R; Gilbert D; Jackson JB; Richards W; Stramer S; Mimms L
Transfusion; 2002 Jul; 42(7):876-85. PubMed ID: 12375660
[TBL] [Abstract][Full Text] [Related]
10. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
Comanor L; Elkin C; Leung K; Krajden M; Kronquist K; Nicolas K; Horansky E; deMedina M; Kittichai P; Sablon E; Ziermann R; Sherlock C
J Clin Virol; 2003 Sep; 28(1):14-26. PubMed ID: 12927747
[TBL] [Abstract][Full Text] [Related]
11. Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay.
Krajden M; Ziermann R; Khan A; Mak A; Leung K; Hendricks D; Comanor L
J Clin Microbiol; 2002 Aug; 40(8):2903-7. PubMed ID: 12149349
[TBL] [Abstract][Full Text] [Related]
12. Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.
Ross RS; Viazov SO; Hoffmann S; Roggendorf M
J Clin Lab Anal; 2001; 15(6):308-13. PubMed ID: 11793430
[TBL] [Abstract][Full Text] [Related]
13. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.
Hofmann WP; Dries V; Herrmann E; Gärtner B; Zeuzem S; Sarrazin C
J Clin Virol; 2005 Apr; 32(4):289-93. PubMed ID: 15780807
[TBL] [Abstract][Full Text] [Related]
15. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays.
May S; Adamska E; Tang JW
J Clin Virol; 2018 Sep; 106():7-10. PubMed ID: 30007139
[TBL] [Abstract][Full Text] [Related]
17. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
Ohhashi Y; Pai A; Halait H; Ziermann R
J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864
[TBL] [Abstract][Full Text] [Related]
18. Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay.
Kolk DP; Dockter J; Linnen J; Ho-Sing-Loy M; Gillotte-Taylor K; McDonough SH; Mimms L; Giachetti C
J Clin Microbiol; 2002 May; 40(5):1761-6. PubMed ID: 11980957
[TBL] [Abstract][Full Text] [Related]
19. Detection of HCV genotypes 1b and 2a by a reverse transcription loop-mediated isothermal amplification assay.
Zhao N; Liu J; Sun D
J Med Virol; 2017 Jun; 89(6):1048-1054. PubMed ID: 27935066
[TBL] [Abstract][Full Text] [Related]
20. Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood.
Tobler LH; Dockter J; Stramer SL; Kleinman SH; Todd D; Giachetti C; Busch MP
Transfusion; 2002 Nov; 42(11):1525-7. PubMed ID: 12421231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
